Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Lejm, Scheepers"'
Publikováno v:
Scandinavian Journal of Rheumatology. 51:390-393
This study aimed to identify lifestyle factors associated with gout in patients with prevalent gout compared to the general population.Adult patients with gout identified in primary and secondary care in Western Sweden between 2015 and 2017 were sent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3aed69750f14d42af8f2a1d0ff87bbda
https://doi.org/10.1080/03009742.2022.2035952
https://doi.org/10.1080/03009742.2022.2035952
Autor:
Laslett LL; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia., Scheepers LEJM; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia., Otahal P; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
Publikováno v:
JAMA [JAMA] 2024 Nov 05; Vol. 332 (17), pp. 1485.
Autor:
Laslett LL; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia., Scheepers LEJM; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia., Antony B; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia., Wluka AE; School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Victoria, Australia., Cai G; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.; Department of Epidemiology and Biostatistics, Anhui Medical University, Hefei, Anhui, China., Hill CL; The Queen Elizabeth Hospital, University of Adelaide, Woodville, South Australia, Australia.; Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia., March L; The University of Sydney, Kolling Institute and Royal North Shore Hospital, Sydney, New South Wales, Australia., Keen HI; Department of Rheumatology, School of Medicine and Pharmacology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.; Medical School, University of Western Australia, Crawley, Western Australia, Australia., Otahal P; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia., Cicuttini FM; School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Victoria, Australia., Jones G; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
Publikováno v:
JAMA [JAMA] 2024 Jun 18; Vol. 331 (23), pp. 1997-2006.
Autor:
Drummen SJJ; University of Tasmania, Hobart, Australia., Aitken D; University of Tasmania, Hobart, Australia., Balogun S; University of Tasmania, Hobart, Australia.; Australian National University, Canberra, Australia., Bennell KL; The University of Melbourne, Melbourne, Australia., Hinman RS; The University of Melbourne, Melbourne, Australia., Callisaya ML; University of Tasmania, Hobart, Australia.; Monash University, Melbourne, Australia., Otahal P; University of Tasmania, Hobart, Australia., Blizzard L; University of Tasmania, Hobart, Australia., Antony B; University of Tasmania, Hobart, Australia., Munugoda IP; University of Tasmania, Hobart, Australia., Winzenberg T; University of Tasmania, Hobart, Australia., Jones G; University of Tasmania, Hobart, Australia., Scheepers LEJM; University of Tasmania, Hobart, Australia.
Publikováno v:
Osteoarthritis and cartilage open [Osteoarthr Cartil Open] 2024 May 14; Vol. 6 (3), pp. 100481. Date of Electronic Publication: 2024 May 14 (Print Publication: 2024).
COPDCompEx: A novel composite endpoint for COPD exacerbations to enable faster clinical development.
Autor:
Vogelmeier CF; Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Marburg, Germany, Member of the German Center for Lung Research (DZL)., Fuhlbrigge A; Pulmonary Sciences and Critical Care, Department of Medicine, University of Colorado School of Medicine, Denver, CO, USA., Jauhiainen A; AstraZeneca, BioPharma Early Biometrics and Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, Gothenburg, Sweden., Scheepers LEJM; AstraZeneca, BioPharma Early Biometrics and Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, Gothenburg, Sweden., Bengtsson T; StatMind Statistical and Mathematical Modelling, Innovation and Design AB, Lund, Sweden., Peterson S; StatMind Statistical and Mathematical Modelling, Innovation and Design AB, Lund, Sweden., Karlsson N; AstraZeneca, BioPharmaceuticals Medical, Gothenburg, Sweden., Sethi T; Emeritus Professor Respiratory Medicine, Kings College, London, UK; Galecto Biotech, London, UK., Locantore N; GlaxoSmithKline R&D, Medical Innovation Value Evidence and Outcomes, Collegeville, PA, USA., Tal-Singer R; GlaxoSmithKline R&D, Medical Innovation Value Evidence and Outcomes, Collegeville, PA, USA., Rennard S; AstraZeneca, BioPharmaceuticals R&D, Cambridge, UK., Fagerås M; AstraZeneca, BioPharmaceuticals Medical, Gothenburg, Sweden., Da Silva CA; AstraZeneca, Early Respiratory & Immunology (R&I) Clinical Development, BioPharmaceuticals R&D, Gothenburg, Sweden. Electronic address: Carla.DaSilva@astrazeneca.com.
Publikováno v:
Respiratory medicine [Respir Med] 2020 Nov; Vol. 173, pp. 106175. Date of Electronic Publication: 2020 Sep 28.
Autor:
Jauhiainen A; BioPharma Early Biometrics and Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Shared first authors., Scheepers LEJM; BioPharma Early Biometrics and Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Shared first authors., Fuhlbrigge AL; Pulmonary Sciences and Critical Care, Dept of Medicine, University of Colorado School of Medicine, Denver, CO, USA., Harrison T; Nottingham NIHR Biomedical Research Centre, Respiratory Medicine, University of Nottingham, Nottingham, UK., Zangrilli J; BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA., Garcia Gil E; BioPharmaceuticals Medical, AstraZeneca, Barcelona, Spain., Gustafson P; BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden., Fagerås M; BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden., Da Silva CA; Early Respiratory and Immunology Clinical Development, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Publikováno v:
ERJ open research [ERJ Open Res] 2020 Oct 19; Vol. 6 (4). Date of Electronic Publication: 2020 Oct 19 (Print Publication: 2020).
Autor:
Scheepers LEJM; Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Electronic address: liekescheepers@hotmail.com., Jacobsson LTH; Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Kern S; Department of Psychiatry and Neurochemistry at Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Johansson L; Department of Psychiatry and Neurochemistry at Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Dehlin M; Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Skoog I; Department of Psychiatry and Neurochemistry at Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publikováno v:
Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2019 Jun; Vol. 15 (6), pp. 754-763. Date of Electronic Publication: 2019 May 02.
Autor:
Scheepers LEJM; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, Maastricht, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; School for Public Health and Primary Care (CAPHRI), Maastricht University Medical Centre, Maastricht, The Netherlands., Burden AM; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; School for Public Health and Primary Care (CAPHRI), Maastricht University Medical Centre, Maastricht, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The Netherlands., Arts ICW; Department of Epidemiology, CARIM School for Cardiovascular Diseases, MaCSBio Maastricht Centre for Systems Biology, Maastricht University, Maastricht, The Netherlands., Spaetgens B; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, Maastricht, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Souverein P; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., de Vries F; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; School for Public Health and Primary Care (CAPHRI), Maastricht University Medical Centre, Maastricht, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The Netherlands., Boonen A; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, Maastricht, The Netherlands.; School for Public Health and Primary Care (CAPHRI), Maastricht University Medical Centre, Maastricht, The Netherlands.
Publikováno v:
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2018 Sep 01; Vol. 57 (9), pp. 1641-1650.
Autor:
Scheepers LEJM; Department of Internal Medicine, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands. Electronic address: lieke.scheepers@maastrichtuniversity.nl., van Onna M; Department of Internal Medicine, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands., Stehouwer CDA; Department of Internal Medicine, CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht, The Netherlands., Singh JA; Medicine Service, Department of Medicine at School of Medicine, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA., Arts ICW; Department of Epidemiology, CARIM School for Cardiovascular Diseases, MaCSBio Maastricht Centre for Systems Biology, Maastricht University, Maastricht, The Netherlands., Boonen A; Department of Internal Medicine, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands.
Publikováno v:
Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2018 Apr; Vol. 47 (5), pp. 689-702. Date of Electronic Publication: 2017 Oct 07.
Autor:
Scheepers LEJM; aDivision of Rheumatology, Department of Internal Medicine, Maastricht University Medical Centre bCAPHRI School for Public Health and Primary Care cCARIM School for Cardiovascular Diseases dDepartment of Epidemiology, Maastricht University eDepartment of Internal Medicine fHeart and Vascular Centre, Maastricht University Medical Centre gMaCSBio Maastricht Centre for Systems Biology, Maastricht University, Maastricht, The Netherlands., Boonen A, Dagnelie PC, Schram MT, van der Kallen CJH, Henry RMA, Kroon AA, Stehouwer CDA, Arts ICW
Publikováno v:
Journal of hypertension [J Hypertens] 2017 Oct; Vol. 35 (10), pp. 1968-1975.